Indikationen und Ergebnisse der Radiojodtherapie beim differenzierten Schilddrüsenkarzinom

BACKGROUND Malignant tumors of the thyroid gland are the most frequent malignant endocrine neoplasms, comprising approximately 1% of all malignant tumors. In recent years there has been a clear rise in the incidence of differentiated thyroid carcinomas (DTC), especially small papillary carcinomas. OBJECTIVE Indications for and results of radioiodine treatment (RAI) of DTC. MATERIAL AND METHODS A review of the current literature and guidelines of RAI in DTC was carried out. RESULTS The use of RAI is the most important adjuvant treatment option for DTC and is generally well-tolerated. CONCLUSION Due to the combination of surgery and RAI the DTC has a very good prognosis compared with other cancers, with an average survival rate of more than 90%.